Bioxytran (BIXT) Gross Profit Growth (3y) (2013 - 2018)
Bioxytran (BIXT) Gross Profit Growth (3y) (2013 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 9.20% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.09% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 77.42% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 28.75% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 45.27% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 59.77% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -45.72% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 80.79% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -35.13% |
| Mar 31, 2018 | -26.83% |
| Dec 31, 2017 | 56.02% |
| Sep 30, 2017 | 123.34% |
| Jun 30, 2017 | -8.07% |
| Mar 31, 2017 | -26.84% |
| Dec 31, 2016 | -19.77% |
| Sep 30, 2016 | 63.08% |
| Jun 30, 2016 | -12.68% |
| Mar 31, 2016 | -47.87% |
| Dec 31, 2015 | -27.54% |
| Sep 30, 2015 | 47.52% |
| Jun 30, 2015 | -18.05% |
| Mar 31, 2015 | -20.52% |
| Dec 31, 2014 | -86.44% |
| Sep 30, 2014 | -10.11% |
| Jun 30, 2014 | 2.40% |
| Mar 31, 2014 | 195.94% |
| Dec 31, 2013 | 162.41% |
| Sep 30, 2013 | 121.14% |